ACADIA Pharmaceuticals Inc.
MX ˙ BMV ˙ US0042251084
SecurityMX:ACAD / ACADIA Pharmaceuticals Inc.
InstitutionRockefeller Capital Management L.P.
Latest Disclosed Ownership1,027,357 shares
Latest Disclosed Value $ 22,868,967
Rockefeller Capital Management L.P. reports 7.70% decrease in ownership of ACAD / ACADIA Pharmaceuticals Inc.

On May 14, 2026 - Rockefeller Capital Management L.P. filed a 13F-HR form disclosing ownership of 1,027,357 shares of ACADIA Pharmaceuticals Inc. (MX:ACAD) valued at $22,868,967 USD as of March 31, 2026. The entity filed a previous 13F-HR/A on March 16, 2026 disclosing 1,113,040 shares of ACADIA Pharmaceuticals Inc.. This represents a change in shares of -7.70% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F ACADIA PHARMACEUTICALS COM 004225108 1,027,357 -85,683 -7.70 22,869 -23.08 0.0406
2026-03-16 2025-12-31 13F/A-1 ACADIA PHARMACEUTICALS COM 004225108 1,113,040 76,727 7.40 29,729 34.44 0.0535
2026-02-14 2025-12-31 13F ACADIA PHARMACEUTICALS COM 004225108 1,113,040 76,727 29,729 0.0271
2025-11-14 2025-09-30 13F ACADIA PHARMACEUTICALS COM 004225108 1,036,313 -128,081 -11.00 22,115 -11.95 0.0433
2025-08-14 2025-06-30 13F/A-1 ACADIA PHARMACEUTICALS COM 004225108 1,164,394 26,300 2.31 25,116 32.86 0.0551
2025-08-08 2025-06-30 13F ACADIA PHARMACEUTICALS COM 004225108 1,164,394 26,300 25,116 0.0317
2025-05-14 2025-03-31 13F ACADIA PHARMACEUTICALS COM 004225108 1,138,094 -25,361 -2.18 18,904 -11.46 0.0467
2025-02-13 2024-12-31 13F ACADIA PHARMACEUTICALS COM 004225108 1,163,455 23,521 2.06 21,349 21.77 0.0553
2024-11-14 2024-09-30 13F ACADIA PHARMACEUTICALS COM 004225108 1,139,934 185,684 19.46 17,532 13.07 0.0472
2024-08-12 2024-06-30 13F ACADIA PHARMACEUTICALS COM 004225108 954,250 165,798 21.03 15,507 6.37 0.0441
2024-05-14 2024-03-31 13F ACADIA PHARMACEUTICALS COM 004225108 788,452 232,115 41.72 14,578 -16.30 0.0426
2024-02-14 2023-12-31 13F ACADIA PHARMACEUTICALS COM 004225108 556,337 51,164 10.13 17,419 65.46 0.0582
2023-11-14 2023-09-30 13F ACADIA PHARMACEUTICALS COM 004225108 505,173 100,884 24.95 10,528 8.73 0.0406
2023-08-14 2023-06-30 13F ACADIA PHARMACEUTICALS COM 004225108 404,289 -76,591 -15.93 9,683 107,477.78 0.0375
2023-05-16 2023-03-31 13F ACADIA PHARMACEUTICALS COM 004225108 480,880 17,239 3.72 9 -99.88 0.0389
2023-03-06 2022-12-31 13F ACADIA PHARMACEUTICALS COM 004225108 463,641 4,811 1.05 7,380 -1.68 0.0371
2022-11-02 2022-09-30 13F ACADIA PHARMACEUTICALS COM 004225108 458,830 23,595 5.42 7,506 22.41 0.0388
2022-08-12 2022-06-30 13F ACADIA PHARMACEUTICALS COM 004225108 435,235 117,500 36.98 6,132 -20.30 0.0326
2022-05-13 2022-03-31 13F ACADIA PHARMACEUTICALS COM 004225108 317,735 15,239 5.04 7,694 9.00 0.0371
2022-02-14 2021-12-31 13F ACADIA PHARMACEUTICALS COM 004225108 302,496 21,268 7.56 7,059 51.12 0.0329
2021-11-12 2021-09-30 13F ACADIA PHARMACEUTICALS COM 004225108 281,228 49,644 21.44 4,671 -17.30 0.0245
2021-08-10 2021-06-30 13F ACADIA PHARMACEUTICALS COM 004225108 231,584 226,222 4,218.99 5,648 3,992.75 0.0318
2021-05-11 2021-03-31 13F ACADIA PHARMACEUTICALS COM 004225108 5,362 2,494 86.96 138 -9.21 0.0009
2021-02-12 2020-12-31 13F ACADIA PHARMACEUTICALS COM 004225108 2,868 -3,094 -51.90 152 -37.96 0.0012
2020-11-13 2020-09-30 13F ACADIA PHARMACEUTICALS COM 004225108 5,962 5,945 34,970.59 245 24,400.00 0.0023
2020-08-12 2020-06-30 13F ACADIA PHARMACEUTICALS COM 004225108 17 17 1 0.0000
2019-08-09 2019-06-30 13F ACADIA PHARMACEUTICALS COM 004225108 0 -68 -100.00 0 -100.00
2019-05-10 2019-03-31 13F ACADIA PHARMACEUTICALS COM 004225108 68 68 2 0.0000
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.